Skip to main content
. 2009 Oct;297(4):L586–L595. doi: 10.1152/ajplung.90569.2008

Fig. 2.

Fig. 2.

TNFα inhibits apoptotic cell clearance by alveolar macrophages in vivo at 90 min. PKH26-labeled apoptotic thymocytes (107 per mouse) were directly instilled into the tracheas of recipient mice simultaneously with TNFα (50 ng) or PBS as a control. Flow cytometry (A–C) and light microscopy (D and E) were used to assess efferocytosis. Macrophages were identified as F4/80+ events. The number of macrophages that were not associated with apoptotic cells (PKH AM) was increased in TNFα-treated mice (A), whereas alveolar macrophages that were associated with apoptotic cells (PKH+ AM) were concomitantly decreased (B). This led to greater recovery of PKH-labeled thymocytes (C). The phagocytic index (number of apoptotic cells ingested per macrophage × 100) was reduced in mice treated with TNFα (D). Impaired removal of apoptotic cells from the lungs of TNFα-treated animals was further supported by an increased recovery of noningested apoptotic thymocytes (E). *P < 0.05 vs. control; **P < 0.01, n = 8 per group.